LINC00174 and colorectal carcinoma: It has been reported that LINC00174 can be used as the ceRNA of miR-1910-3p, regulating the target gene TAZ to facilitate the progress of CRC [16], suggesting that LINC00174 can be used as a new drug therapy target for CRC.